SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-20-290910
Filing Date
2020-11-12
Accepted
2020-11-12 06:08:19
Documents
11

Document Format Files

Seq Description Document Type Size
1 424B3 d29194d424b3.htm 424B3 4268947
2 GRAPHIC g29194g10m60.jpg GRAPHIC 109212
3 GRAPHIC g29194g15x25.jpg GRAPHIC 307657
4 GRAPHIC g29194g25a58.jpg GRAPHIC 46827
5 GRAPHIC g29194g48d68.jpg GRAPHIC 49560
6 GRAPHIC g29194g50c23.jpg GRAPHIC 101396
7 GRAPHIC g29194g50l32.jpg GRAPHIC 77717
8 GRAPHIC g29194g60m58.jpg GRAPHIC 205816
9 GRAPHIC g29194g65x34.jpg GRAPHIC 66945
10 GRAPHIC g29194g69a00.jpg GRAPHIC 128646
11 GRAPHIC g29194g95l31.jpg GRAPHIC 34412
  Complete submission text file 0001193125-20-290910.txt   5775317
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-248993 | Film No.: 201302968
SIC: 2834 Pharmaceutical Preparations